title: In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment.
authors.forename: Olavio R
authors.initials: OR
authors.lastname: Baricordi
authors.forename: Marcello
authors.initials: M
authors.lastname: Govoni
authors.forename: Roberta
authors.initials: R
authors.lastname: Rizzo
authors.forename: Francesco
authors.initials: F
authors.lastname: Trotta
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D005838:Genotype; D006680:HLA Antigens / Q000235:genetics*; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000235:genetics*; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D011110:Polymorphism, Genetic; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D006680:HLA Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I; D008727:Methotrexate